Magnetic resonance imaging (MRI) provides high resolution brain morphological information and is used as a biomarker in neurodegenerative diseases. Population studies of brain morphology often seek to identify pathological structural changes related to different diagnostic categories (e.g: controls, mild cognitive impairment or dementia) which normally describe highly heterogeneous groups with a single categorical variable. Instead, multiple biomarkers are used as a proxy for pathology and are m...
Casamitjana, A. [et al.]. Shared latent structures between imaging features and biomarkers in early stages of Alzheimer's disease: a predictive study. "IEEE Journal of Biomedical and Health Informatics", 1 Agost 2019.